2012 - Side 7
Cand.med. David Scheie ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): 1p/19q loss in oligodendroglial tumours - methodological, histological, radiological and clinical aspects
Cand.med. Hanne-Sofie Spenning Dahlback ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Cytogenetic and Molecular Cytogenetic Analyses of Brain Tumours
Cand.med. Liv Ingrid Karine Flinder ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Adhesion dependency of growth factor-mediated responses in primary hepatocytes.
Cand.med. Pål Gunnar Larsson ved Institutt for klinisk medisin vil forsvare sin avhandling for graden dr.philos.: Automated monitoring of EEG background and epileptiform activity with special reference to antiepileptic drug treatment
Cand.med. Christine Sachs-Olsen ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Exhaled markers of airway inflammation. Helpful in diagnosis and characterisation of asthma and allergy in childhood?
Siv.ing. Lena Tjeldhorn ved Institutt for klinsik medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Protein C deficiency-molecular and functional studies on the protein C A267T mutation.
Cand.med. Jan Otto Beitnes ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Cell therapy in acute myocardial infarction.
Cand.med. Ann Christin Gjerstad ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Is Skin Conductance a predictor of arousal, noxious stimuli and pain in the sedated and anaesthetized patient?
Cand.med. Halldóra Jónsdóttir ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Adherence to pharmacological treatment in patients with severe mental disorders
M.Sc. Beate Skinningsrud ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Genetic mapping in Addison’s disease and other autoimmune disorders.
Cand.med. Trond Vartdal ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Early Assessment of Infarct Size and Left Ventricular Remodeling by Strain Echocardiography.
Cand.med. Kari Lima ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): The 22q11.2 Deletion Syndrome -Clinical, immunological, endocrine and dental aspects .
Cand.med. Birgitte Karen Berggren Seip ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (Philosophiae doctor): Improving the quality of Gastrointestinal endoscopy service.
Cand.med. Benthe Sjøli ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Diagnostic and prognostic use of myocardial strain in patients with acute myocardial infarction.
M.Sc. Lavinia Athanasiu ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Whole genome analysis of genetic susceptibility factors in psychotic disorders
Cand.med. Ole Marius Ekeberg ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Rotator cuff disease; aspects concerning injection treatment, outcome assessment and short-term prognosis.
Sykepleier John-Kåre Vederhus ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Addiction professionals’ and substance abuse patients’ attitudes towards and usage of 12-step-based self-help groups
Cand.med. Hanna Dis Margeirsdottir ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Atherosclerosis and childhood diabetes.
Cand.med. Elisabeth Lie ved Institutt for klinisk medisin vil forsvare sin avhandling for graden ph.d. (philosophiae doctor): Effectiveness of synthetic and biological disease modifying antirheumatic drugs in patients with inflammatory joint diseases. Results from the NOR-DMARD register.